Neuromod Devices has named two senior commercial leaders as it works to scale access to its Lenire bimodal neuromodulation tinnitus treatment device globally. Neuromod Devices has appointed Joe Ghiz as chief commercial officer (CCO) and Shannon Basham as VP of channel development, the Dublin-based medical technology company announced Oct. 1, 2026....
Continue reading at Hearing Review
✦ The floor
Discussion
Signed responses from readers of the wire.
✦ Clinical Takeaway ✦
No actionable change — this is a corporate staffing announcement with no clinical implications.
✦ Why It Matters ✦
Leadership investment in commercial expansion signals that Neuromod is pushing harder to bring bimodal neuromodulation tinnitus therapy into mainstream audiology channels globally.
✦ Key Points ✦
- 01Neuromod Devices appointed Joe Ghiz as Chief Commercial Officer.
- 02Shannon Basham named VP of Channel Development to grow distribution networks.
- 03Both hires are focused on expanding global reach of the Lenire tinnitus device.
- 04Lenire uses bimodal neuromodulation — combining sound and tongue stimulation — to treat tinnitus.
